Breast Cancer Clinical Trial Using BYL719, BKM120 and Placebo

- The folks at Novartis are studying the effects of BYL719; BKM120; Placebo on Breast Cancer in females ages 18 years and older. This clinical trial is slated to start January 2014 and is expected to end circa September 2016.

1-888-669-6682
Overall Study Contact Info
StatusName Contact Phone
RecruitingNovartis Pharmaceuticals1-888-669-6682

This study is officially titled, "A Phase II Randomized, Double-blind Placebo Controlled, Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women With Hormone Receptor-positive HER2-negative Breast Cancer."

Locations

University of Alabama at Birmingham/ Kirklin Clinic Univ AL - PI

Birmingham, Alabama - Not yet recruiting

University of Arizona / Arizona Cancer Center BYL791A2201

Tucson, Arizona - Not yet recruiting

Highlands Oncology Group Dept of Highlands Oncology Grp

Fayetteville, Arkansas - Not yet recruiting

University of California at Los Angeles UCLA SC

Los Angeles, California - Not yet recruiting

Comprehensive Cancer Center SC

Palm Springs, California - Not yet recruiting

University of California San Francisco BYL719A2201 - SC

San Francisco, California - Recruiting

Sutter Pacific Medical Foundation

Santa Rosa, California - Not yet recruiting

Emory University School of Medicine/Winship Cancer Institute BYL719A2201

Atlanta, Georgia - Not yet recruiting

NorthwesternUniv.Med.School/Robert H. Lurie Comp.Cancer Ctr

Chicago, Illinois - Not yet recruiting

Indiana University Simon Cancer Center

Indianapolis, Indiana - Not yet recruiting

Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Med. Johns Hopkins Med. BYL719A2201

Baltimore, Maryland - Not yet recruiting

Dana Farber Cancer Institute BYL719A2201

Boston, Massachusetts - Not yet recruiting

Mayo Clinic - Rochester BYL719A2201 - SC

Rochester, Minnesota - Not yet recruiting

Cancer Institute of New Jersey

New Brunswick, New Jersey - Not yet recruiting

University of North Carolina UNC 2

Chapel Hill, North Carolina - Not yet recruiting

Duke University Medical Center Duke University Medical Center

Durham, North Carolina - Not yet recruiting

Cone Health Cancer Center

Greensboro, North Carolina - Withdrawn

Magee Womens Hospital BYL719A2201

Pittsburgh, Pennsylvania - Not yet recruiting

Vanderbilt Ingram Cancer Center Vanderbilt Health 100 Oaks

Nashville, Tennessee - Not yet recruiting

US Oncology Central Monitoring

Dallas, Texas - Withdrawn

MD Anderson Cancer Center/University of Texas MD Anderson

Houston, Texas - Not yet recruiting

Seattle Cancer Care Alliance/Fred Hutchinson Cancer Research SC-3

Seattle, Washington - Not yet recruiting

Northwest Medical Specialties Dept.ofNW Med. Specialties

Tacoma, Washington - Not yet recruiting

Novartis Investigative Site

Kingswood, New South Wales - Not yet recruiting

Novartis Investigative Site

Woodville, South Australia - Not yet recruiting

Novartis Investigative Site

Perth, Western Australia - Not yet recruiting

Novartis Investigative Site

Innsbruck, Austria - Not yet recruiting

Novartis Investigative Site

Leoben, Austria - Not yet recruiting

Novartis Investigative Site

Salzburg, Austria - Not yet recruiting

Novartis Investigative Site

Vienna, Austria - Not yet recruiting

Novartis Investigative Site

Wien, Austria - Not yet recruiting

Novartis Investigative Site

Charleroi, Belgium - Not yet recruiting

Novartis Investigative Site

Edegem, Belgium - Not yet recruiting

Novartis Investigative Site

Gent, Belgium - Not yet recruiting

Novartis Investigative Site

Leuven, Belgium - Not yet recruiting

Novartis Investigative Site

Namur, Belgium - Withdrawn

Novartis Investigative Site

Edmonton, Alberta - Not yet recruiting

Novartis Investigative Site

Vancouver, British Columbia - Not yet recruiting

Novartis Investigative Site

Montreal, Quebec - Not yet recruiting

Novartis Investigative Site

Quebec, Canada - Not yet recruiting

Novartis Investigative Site

Bogot , Colombia - Not yet recruiting

Novartis Investigative Site

Besan‡on cedex, France - Not yet recruiting

Novartis Investigative Site

Lyon Cedex, France - Not yet recruiting

Novartis Investigative Site

Marseille, France - Not yet recruiting

Novartis Investigative Site

Paris, France - Not yet recruiting

Novartis Investigative Site

Paris, France - Not yet recruiting

Novartis Investigative Site

Saint Herblain cedex, France - Not yet recruiting

Novartis Investigative Site

Villejuif Cedex, France - Not yet recruiting

Novartis Investigative Site

Berlin, Germany - Not yet recruiting

Novartis Investigative Site

Erlangen, Germany - Not yet recruiting

Novartis Investigative Site

Essen, Germany - Not yet recruiting

Novartis Investigative Site

Kiel, Germany - Not yet recruiting

Novartis Investigative Site

Koeln, Germany - Not yet recruiting

Novartis Investigative Site

Mnchen, Germany - Not yet recruiting

Novartis Investigative Site

Cremona, CR - Not yet recruiting

Novartis Investigative Site

Macerata, MC - Not yet recruiting

Novartis Investigative Site

Roma, RM - Not yet recruiting

Novartis Investigative Site

Sassari, SS - Not yet recruiting

Novartis Investigative Site

Terni, TN - Not yet recruiting

Novartis Investigative Site

Milano, Italy - Not yet recruiting

Novartis Investigative Site

Delft, Netherlands - Not yet recruiting

Novartis Investigative Site

Den Haag, Netherlands - Not yet recruiting

Novartis Investigative Site

Eindhoven, Netherlands - Withdrawn

Novartis Investigative Site

Leiden, Netherlands - Not yet recruiting

Novartis Investigative Site

Pretoria, Gauteng - Not yet recruiting

Novartis Investigative Site

Johannesburg, South Africa - Not yet recruiting

Novartis Investigative Site

Hospitalet de LLobregat, Catalunya - Not yet recruiting

Novartis Investigative Site

Valencia, Comunidad Valenciana - Not yet recruiting

Novartis Investigative Site

San Sebastian, Pais Vasco - Not yet recruiting

Novartis Investigative Site

Madrid, Spain - Not yet recruiting

Novartis Investigative Site

Madrid, Spain - Not yet recruiting

For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.